| Followers | 558 |
| Posts | 31279 |
| Boards Moderated | 1 |
| Alias Born | 12/22/2006 |
Sunday, January 31, 2021 7:49:48 PM
You are incorrect. RVVTF anyone not buying early this week is imo about to miss out on waking up to the stock gapping up to $5 or more on approval news.
I have always expected the FDA to give the go ahead with this in early to mid Feb.
Well? Feb is here.
Go time.
I have always expected the FDA to give the go ahead with this in early to mid Feb.
Well? Feb is here.
Go time.
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
